Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma
- PMID: 30117772
- DOI: 10.3171/2018.6.JNS181418
Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma
Comment on
-
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.J Neurosurg. 2018 Jul;129(1):35-47. doi: 10.3171/2016.11.JNS161170. Epub 2017 Oct 6. J Neurosurg. 2018. PMID: 28984517 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources

